News | Published:

Profile: Heinrich Henckel

Nature Biotechnologyvolume 23page773 (2005) | Download Citation

Subjects

Conventional wisdom is that biotech floatations in Europe belong on the London stock market. But the CEO of the Swiss stock exchange is bullish about the advantages of his exchange for life science ventures.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Author information

Affiliations

  1. Dublin

    • Sabine Louët

Authors

  1. Search for Sabine Louët in:

Related links

Related links

Related links in Nature Research

European markets target foreign biotechs

Web links

SWX

London Stock Exchange

About this article

Publication history

Published

Issue Date

DOI

https://doi.org/10.1038/nbt0705-773

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing